• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconShire

Shire

Shire Plc Chief Executive Officer Flemming Ornskov Interview
HealthUPDATED: Rare Disease Drug Maker Shire’s Stock Spikes Amid Possible Bidding War Between Allergan and Takeda
By Sy MukherjeeApril 19, 2018
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthDrugmaker Shire Is Buying Baxalta for $32 Billion
By ReutersJanuary 11, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthShire-Baxalta $32 Billion Merger Talks Said to Advance
By Michal AddadyJanuary 3, 2016
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
HealthShire offers to buy rival drugmaker Baxalta for $30 billion
By ReutersAugust 4, 2015
Traders At The NYSE React To Malaysian Airliner Crash In Ukraine
FinanceMarkets end week with a rally, despite geopolitical turmoil
By Tom Huddleston Jr.July 18, 2014
FinanceAre U.S. corporate tax inversions a necessary crisis?
By Robert LitanJuly 18, 2014
1
  • 1
1
Most Popular
Economy
Your grandparents are the reason the U.S. isn't in a recession right now. That won't last foreverAn image of a popular article
By Eleanor PringleMarch 1, 2026
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put Scott on the path to give more than $1 billion to HBCUsAn image of a popular article
By Sasha RogelbergMarch 1, 2026
Middle East
U.S. military gives Iran a taste of its own medicine with cheap copycat Shahed drones, while concern shifts to munitions supply in extended conflictAn image of a popular article
By Jason MaMarch 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.